Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03705793 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis
A Phase 4 study of Chronic Rhinosinusitis (Diagnosis) and Allergic Rhinosinusitis, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 53
- Enrollment target
- 2
- Study locations
NCT03705793 is a Phase 4 study of Chronic Rhinosinusitis (Diagnosis) and Allergic Rhinosinusitis that has completed, run by Washington University School of Medicine. The registered enrollment target is 53 participants, below the 85-participant average among 9 other Chronic Rhinosinusitis (Diagnosis) trials with a reported enrollment target (38% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03705793, a Phase 4 study of Chronic Rhinosinusitis (Diagnosis) and Allergic Rhinosinusitis, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 53 participants
- Enrollment target
- 2
- Study locations
Study Summary
Chronic rhinosinusitis (CRS) affects up to 12.5% of the US population and has a significant disease burden. The recommended medical management of CRS includes large-volume, low-pressure saline lavage, systemic antibiotics, and intranasal corticosteroids (INCS). While the efficacy and safety of INCS are well-established for the long-term management of CRS, penetration of INCS beyond the nasal vestibule and into the paranasal sinuses is limited. The aim of this study is to evaluate the effectiveness of mometasone furoate large-volume, low-pressure nasal irrigation for surgery-naive CRS patients.
Conditions Studied
Interventions
- DRUG Mometasone Furoate Nasal Irrigation
- DRUG Mometasone Nasal Spray
Study Locations (2)
Missouri
- Washington University School of Medicine - St Louis
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2020-03-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03705793
The ClinicalTrials.gov registry entry for NCT03705793 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 85-participant average among 9 other Chronic Rhinosinusitis (Diagnosis) trials with a reported enrollment target (38% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Chronic Rhinosinusitis (Diagnosis) appearing as the primary indexed condition, and to 2 interventions - of which Mometasone Furoate Nasal Irrigation is the first listed.
NCT03705793 reports 2 study locations spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT03705793 about?
NCT03705793 is a clinical study titled "Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis". Chronic rhinosinusitis (CRS) affects up to 12.5% of the US population and has a significant disease burden. The recommended medical management of CRS includes large-volume, low-pressure saline lavage, systemic antibiotics, and intranasal corticosteroids (INCS). While the efficacy and safety of INCS ...
What is the current status of trial NCT03705793?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 53 participants. The study started on 2019-01-01. Estimated completion is 2020-03-15.
What conditions does trial NCT03705793 study?
This clinical trial studies the following conditions: Chronic Rhinosinusitis (Diagnosis), Allergic Rhinosinusitis, Chronic Eosinophilic Rhinosinusitis.
What interventions are being tested in trial NCT03705793?
The interventions under investigation include: Mometasone Furoate Nasal Irrigation (DRUG), Mometasone Nasal Spray (DRUG).
Who is sponsoring clinical trial NCT03705793?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03705793 being conducted?
This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Rhinosinusitis (Diagnosis)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
RECRUITING · Early Phase 1
-
The Role of IL5 in Epithelial Cell Integrity
RECRUITING · Early Phase 1
-
Sinus Disease in Young Children With Cystic Fibrosis
RECRUITING
-
Topical Probiotic Sinus Irrigations for Treating Chronic Sinusitis
RECRUITING · Phase 2
-
Impact of Sinus Surgery on Individuals With Cystic Fibrosis
RECRUITING
-
The Sinonasal Microbiome
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.